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Abstract  
Objective: Breast reconstruction is associated with multiple psychological benefits. 
However, few studies have identified clinical and psychological factors associated with 
improved satisfaction and quality of life. This study examined factors which predict 
satisfaction with breast appearance, outcome satisfaction and quality of life following post-
mastectomy breast reconstruction.   
Methods: Women who underwent post-mastectomy breast reconstruction between 2010 and 
2016 received a postal questionnaire consisting of: The BREAST-Q Patient Reported 
Outcomes Instrument, The European Organisation for Research and Treatment of Cancer 
QLQ-30 Questionnaire, The Patient and Observer Scar Assessment Scale and a series of 
Visual-Analogue Scales. One hundred and forty eight women completed the questionnaire, a 
56% response rate.  
Results: Hierarchical multiple regression analyses revealed psychosocial factors accounted 
for 75% of the variance in breast satisfaction, 68% for outcome satisfaction and 46% for 
quality of life. Psychosocial wellbeing emerged as a significant predictor of satisfaction with 
breast appearance (β=.322) and outcome satisfaction (β=.406). Deep inferior epigastric 
perforator flap (DIEP) patients reported greater satisfaction with breast appearance (β=.120) 
and outcome satisfaction (β=.167).  
Conclusions: This study extends beyond the limited research by distinguishing between 
satisfaction with breast appearance and outcome satisfaction. The study provides evidence for 
the role of psychosocial factors predicting key patient reported outcomes and demonstrates 
the importance of psychosocial wellbeing and reconstruction type. The findings also highlight 
the need for healthcare providers to consider the psychosocial wellbeing of patients both pre 
and post operatively, and provide preliminary evidence for the use of DIEP reconstructions 
over other types of reconstructive procedures. 
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Background  
Globally, breast cancer is the most common malignancy among women [1]. In the United 
Kingdom and the United States the estimated lifetime risk of breast cancer is 1 in 8 [2], with 
over 40,000 new cases diagnosed in the United Kingdom [3], and over 230,000 in the United 
States each year [4]. Today, women with a history of breast cancer constitute the largest 
group of cancer survivors [5]. Improved survival rates have placed increased importance on 
promoting and supporting a high quality of life and optimal psychosocial adjustment among 
breast cancer survivors. The primary treatment for breast cancer is surgical, consisting of 
either a mastectomy or breast conservation surgery [5]. Despite the increasing use of breast 
conservation surgery, there has been a steady increase in the number of women electing to 
undergo mastectomy [6]. This may be partially attributed to the incorporation of 
reconstructive options into mainstream breast cancer surgery treatment. For many women a 
mastectomy can lead to a range of long-term psychosocial sequela [7], including anxiety and 
depression, as well as psychosexual changes including body image disturbance, loss of 
femininity and attractiveness, and decreased sexual desire and/or sexual pleasure [7-10].  
Post-mastectomy options include using an external prosthesis, undergoing breast 
reconstruction surgery or deciding to have no prosthesis or reconstruction. An external 
prosthesis is an artificial breast form, moulded to imitate the natural shape of a woman’s 
breast [11]. Many women have reported the use of an external prosthesis as somewhat 
inconvenient describing the prosthesis as difficult to keep in place, uncomfortable and 
limiting in terms of both clothing options and physical activity [8].Breast reconstruction may 
provide an effective solution to the problems associated with the use of an external 
prosthesis. Women undergo breast reconstruction for a variety of reasons; including the 
desire to improve body image [12], restore feelings of wholeness and body integrity [13], a 
reluctance to wear a limiting external prosthesis and the ability to wear a greater variety of 
clothing [14]. However, the decision to reconstruct the breast is complex and incorporates 
patient preference, treatment history, anticipated postoperative treatment and anatomy, 
specifically the size/shape of the breasts [15]. The primary goal of breast reconstruction is to 
obtain the best aesthetic outcome [16]. The surgeon in consultation with the patient must 
decide between the different methods of reconstruction (autologous tissue or implant or a 
combination of both) and the timing of reconstruction, which could be either during the same 
procedure as mastectomy (immediate) or at a later stage (delayed). In the United Kingdom, 
the National Institute of Clinical Excellence (NICE) recommends that breast reconstruction is 
offered to all women following mastectomy [17]. In England and Wales approximately 21% 
of women undergo breast reconstruction [18]. Internationally, breast-reconstruction rates 
vary; the United States report rates between 24.8%-59% [19, 20], and Australia and Denmark 
report rates of 9% and 14% respectively [21, 22].   
For many women breast reconstruction is associated with psychological benefits including 
improved appearance satisfaction, re-established psychological wellbeing [23] and positive 
effects on body image and self-esteem [24]. Moreover, breast reconstruction may help to 
strengthen the affective and sexual relationship of couples [25]. Some studies suggest breast 
reconstruction is one of the most important determinants of long-term health and wellbeing 
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among breast cancer survivors [26]. These benefits have been observed for both immediate 
and delayed reconstructions [27] and across a number of procedures [26]. However, some 
studies have reported similar patient outcomes following breast reconstruction compared to 
breast conservation surgery or mastectomy alone [28], with one study reporting poorer 
psychosocial functioning and increased mood disturbance in patients who underwent 
reconstruction compared to mastectomy alone [27]. Complications with the reconstructed 
breast and abdominal problems have been identified as key causes of dissatisfaction with 
breast reconstruction [29]. The type of breast reconstruction may also influence patient 
satisfaction. For example, autologous tissue reconstruction (using a patient’s own tissue to 
reconstruct the breast), involves scarring to the breast and donor-site and donor-site morbidity 
(complications at this site as it heals) [30]. Additionally, women may be required or choose to 
undergo additional surgery following the reconstruction, including nipple reconstruction, 
reshaping a flap, removing extra fat from a donor site, or repositioning the implant [31]. Yet, 
scarring as an area of potential dissatisfaction is neglected within current literature [32].  
Restoration of psychological wellbeing is a key objective for postmastectomy women 
undergoing breast reconstruction. Therefore, patient satisfaction (which reflects the patient’s 
assessment of the achievement of personal benefits of the procedure) is an important marker 
of surgical success in breast reconstruction, as the overall goal is to satisfy patients with 
respect to improvement in the appearance of their breasts and psychosocial functioning [33].  
Patient satisfaction measures have been reported as a primary and useful source of feedback 
within healthcare services and many patients report high levels of satisfaction following 
breast reconstruction [34]. However, the value of distinguishing between satisfaction with the 
appearance of the breasts (e.g., size, shape and symmetry) and satisfaction with the overall 
outcome (e.g., overall evaluation of surgery, expectations and decision regret) is under-
recognised within the field of psycho-oncology. Moreover, a central rationale in the majority 
of healthcare interventions is the improvement in one or more aspects of a patient’s quality of 
life, and contemporary literature indicates improved quality of life following posy-
mastectomy breast reconstruction [33].  
Beyond the evidence that breast reconstruction may be positively associated with satisfaction 
and improved quality of life, few studies have attempted to identify the key factors that are 
involved in determining levels of reported satisfaction and quality of life. For example, one 
study reported 93% of women were satisfied with their breast reconstruction, but the reasons 
for their satisfaction were not explored [35]. Yet, satisfaction is often based on a range of 
factors, although few studies distinguish between breast satisfaction and outcome satisfaction. 
The primary aim of this study was to identify the factors which predict satisfaction with 
breast appearance in a group of patients who had undergone post-mastectomy breast 
reconstruction. The secondary aim was to identify whether the same or different factors 
predict outcome satisfaction and global quality of life.  
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Methods  
Design  
The present study utilised a cross sectional retrospective questionnaire design, which 
examined predictors of satisfaction with breast appearance, outcome satisfaction and global 
quality of life following post-mastectomy breast reconstruction.  
Procedure and participants  
Ethical approval was granted by a university ethics committee and a local NHS trust 
committee (GF0095). Study eligibility criteria consisted of breast reconstruction following 
breast cancer patients, who were aged 18 and over with no breast cancer recurrence or 
palliative treatment. Eligible participants were identified from patient lists of two Consultant 
Plastic Surgeons based in one teaching hospital. In total 263 women were identified as 
eligible. A postal questionnaire was administered to all eligible women, along with 
information regarding the purpose of the study, a consent form, an opt-out slip, and 
instructions on how to complete the questionnaire and two stamped addressed envelopes for 
the return of the questionnaire and consent form /opt-out slip. Two weeks after the initial 
postal administration 71 women had responded. A further 192 second questionnaires and 
reminder letters were sent to those women who had not yet responded. One hundred and forty 
eight responders completed and returned the questionnaire (a response rate of 56%). 
Responders were asked to provide consent to the release of their demographic details and 
relevant sections of their medical notes. Demographic and clinical characteristics of the 
sample are displayed in Table 1. Nine women did not provide consent for their details to be 
released. The mean age of participants was 55 years (SD=8.70), with women aged between 
32-76 years old and 84% of participants were White-British.   
Measures  
The Breast-Q Scale (reconstruction model): a validated patient-report outcome 
questionnaire, which evaluates outcomes among women after breast reconstruction. The scale 
comprised 57 items divided into five modules: (1) satisfaction with breasts, (2) satisfaction 
with outcome, (3) psychosocial wellbeing (4) sexual wellbeing and (5) physical wellbeing. 
The validity and reliability of the Breast-Q has been established within this patient population 
[36]. The measure used a 4 point scale ranging from 1 (very dissatisfied/disagree/none of the 
time) to 4 (very satisfied/agree/all of the time). Scores were transformed using Q-Score 
scoring software (Q-ScoreTM Version 1.0) to provide a total score ranging from 0-100. Higher 
scores indicated greater satisfaction or quality of life.  
The European Organisation for Research and Treatment of Cancer (EORTC QLQ-30) 
measure: a 30 item standardised, self-administered measure which assessed health related 
quality of life of cancer patients. The scale comprised five functional scales (physical, role, 
cognitive, emotional and social), three symptom scales (fatigue, pain and nausea), a number 
of single items which assessed commonly reported symptoms of cancer patients (dyspnoea, 
loss of appetite, insomnia, constipation and diarrhoea) and the financial impact of the disease. 
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Items 1-28 ranged from: 1 (not at all) to 4 (very much). Items 29 and 30 are single items 
which assessed global health status and quality of life and ranged from 1 (very poor) to 7 
(excellent). High scores on these items represented high global health status and quality of 
life. A linear transformation was used to standardise the raw scores, on a scale of 0–100. 
High scores on the functional scales indicated good functioning, although high scores on the 
symptom scales indicated a greater number of symptoms. The validity and reliability of this 
measure has been established [37].   
Patient and Observer Scar Assessment Scale (POSAS): is a self-administered scale which 
measures scar quality of the breast and donor sites from the patients’ perspective. This 7 item 
measure utilised a 10-point scale, which ranged from 10 (worst imaginable scar or sensation) 
to 1 (as normal skin) on seven scar features including: pain, itching, colour, pliability, 
thickness, relief and overall scar quality. The validity and reliability of the POSAS measure 
has been established within this patient population [38]. A total score for each scar feature 
was obtained by reversing and summing the six specific scar items. Overall scar quality was 
scored separately, reversed and summed. A higher score indicated greater satisfaction with 
the scar features and overall scar quality.  
A series of Visual Analogue Scales (VAS) were developed to examine the aesthetic features 
of breast in three dimensions: symmetry, shape and sensitivity. Each dimension utilised a 
10cm horizontal VAS scale which ranged from 1 (complete satisfaction) to 10 (complete 
dissatisfaction). The scores from each dimension were reversed and summed to provide three 
total scores for symmetry, shape and sensitivity. A higher score indicated greater satisfaction 
with aesthetic features of breast.  
Statistical analysis  
Three hierarchical multiple regression analyses were performed for three dependent 
variables: satisfaction with breast appearance, outcome satisfaction and global quality of life. 
In the analysis, the appearance related visual analogue measures and the Breast Q measure 
(“satisfaction with breasts”) were entered at stage one. The POSAS scarring variables were 
entered at stage two and a variable from the Breast Q measure (“satisfaction with outcome”) 
was entered at stage three. In the final stage of the model EORTC quality of life variable 
(“global quality of life”) and the Breast Q measures (“psychosocial wellbeing and sexual 
wellbeing”) were entered. A moderator analysis was performed to determine if participants’ 
age, date of reconstruction or type of reconstruction moderated the dependent variables.  
Results 
 
Preliminary analyses were performed to test the assumption of normality and 
multicollinearity. The analyses suggested there was no violation of normality. Histograms 
were symmetrical and approximately bell-shaped, indicating normal distribution. The normal 
probability plots also indicated that the residuals were normally distributed. Collinearity 
statistics guidelines state if the largest Variance Inflation Factor (VIF) is greater than 10 and 
if the average VIF is substantially greater than 1 the regression may be biased [39]. Tolerance 
< 0.2 also indicates a potential problem [39]. In the present study, the analyses did not meet 
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any of the criteria, suggesting multicollinearity was not present. Three separate hierarchical 
multiple regression analyses were performed:  
Satisfaction with breast appearance 
Hierarchical multiple regression analysis revealed that at stage one, appearance variables 
contributed significantly to the regression model, (F (6, 98) = 23.87, p< .001) and accounted 
for 59% of the variation in satisfaction with breast appearance. The scarring variables 
explained an additional 8% of variation in satisfaction with breast appearance and this change 
in R² was significant, (F (7, 91) =3. 12, p=.005). Introducing the variable outcome 
satisfaction to the regression model explained an additional 10% of the variation in 
satisfaction with breast appearance and this change in R² was significant, (F (1, 90) = 9.57, 
p=003). Finally, the addition of quality of life measures (psychosocial wellbeing, sexual 
wellbeing and global quality of life) to the regression model explained an additional 4% of 
the variation in Satisfaction and this change in R² square was significant, (F (3, 87) = 4.71, 
p=.004). The final model accounted for 75% of variance in satisfaction with breast 
appearance (F(17, 87)= 14.96, p=<.001, R2 = .745, R2Adjusted = .695 (Table 2: Accessible 
online via supplementary material). In the final model psychosocial wellbeing was found 
to be the most important predictor variable of satisfaction with breast appearance (β =.322, 
p=.006). Moderator analysis also demonstrated participant age (β=.011, p=.865) did not 
significantly moderate breast satisfaction. However, there was a trend between breast 
satisfaction and type of reconstruction (β=.120, p=.073), with higher levels of satisfaction of 
breast appearance demonstrated with Deep Inferior Epigastric Perforator Flap (DIEP) 
reconstruction compared to other types of reconstruction. The date of reconstruction (β=.148, 
p=.029) significantly moderated satisfaction with breast appearance. A one year increase in 
the date of reconstruction between 2010 and 2016 resulted in a .148 increase in breast 
satisfaction.  
Outcome satisfaction  
Hierarchical multiple regression analysis revealed that at stage one, appearance variables 
contributed significantly to the regression model, (F (7, 97) = 16.75, p< .001) and accounted 
for 55% of the variation in outcome satisfaction. Introducing the scarring variables explained 
an additional 6% of variation in satisfaction with breast reconstruction outcome and this 
change in R² was significant, (F (7, 90) = 2.05, p=.057). The addition of quality of life 
measures (psychosocial wellbeing, sexual wellbeing and global quality of life) to the 
regression model explained an additional 7% of the variation in satisfaction and this change 
in R² square was significant, (F (3, 87) = 5.99, p=.001). The final model accounted for 67.7% 
of variance of outcome satisfaction (F(17, 87)= 10.71, p=<.001, R2 = .677, R2Adjusted = .613 
(Table 3: Accessible online via supplementary material). The factors found to be the most 
important predictors of outcome satisfaction were breast sensitivity (β= -.169, p=.014), pain 
(β= -.204, p=.018), scar thickness (β=.369,p=041) and psychosocial wellbeing (β=.406, 
p=.002). Moderator analysis demonstrated participant age (β= -.018,p=.804) and date of 
reconstruction (β=.005, p=.950) did not significantly moderate outcome satisfaction, although 
type of reconstruction did significantly moderate outcome satisfaction  (β=.167,p=.026), with 
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significantly higher levels of outcome satisfaction demonstrated with DIEP reconstruction 
compared to other types of reconstruction. 
Global quality of life 
Hierarchical multiple regression analysis revealed that at stage one, appearance variables 
contributed significantly to the regression model, (F (7, 97) = 5.85, p< .001) and accounted 
for 30% of the variation in global quality of life. Introducing the scarring variables explained 
an additional 11% of variation in global quality of life and this change in R² was significant, 
(F (7, 90) = 2.29, p=.034). Adding the variable satisfaction of the overall outcome explained 
an additional 0.6% of the variation in global quality of life and this change in R² was non-
significant, (F (1, 89) = .950, p= .332). The addition of quality of life measures (psychosocial 
wellbeing, sexual wellbeing and global quality of life) to the regression model explained an 
additional 5.3% of the variation in global quality of life and this change in R² square was also 
significant, (F (17, 87) = 4.25, p= .017). Together all independent variables accounted for 
46% of variance in global quality of life (F (23, 81) = 4.40, p=<.001, R2 = .46.2, R2Adjusted = 
.357 (Table 4: Accessible online via supplementary material). In the final model no one 
variable was found to be a significantly more important predictor of quality of life than 
another. Moderator analysis demonstrated participant age (β=.004, p=.962), type of 
reconstruction (β=-087, p=.371) and date of reconstruction (β=-730, p=.467) did not 
significantly moderate global quality of life.  
Discussion  
This study identified psychosocial factors which predicted satisfaction with breast 
appearance, outcome satisfaction and global quality of life following post-mastectomy breast 
reconstruction. The results of the hierarchical multiple regression analyses revealed 
individual psychosocial factors were able to predict a high percentage of the total variance for 
both satisfaction with breast appearance and outcome satisfaction, approximately 75% and 
68% respectively. The total variance explained by the model for quality of life was more 
modest (46%). The findings of this study are consistent with the theoretical framework of 
breast reconstruction presented by Fingeret and Colleagues [34] and highlight the importance 
of distinguishing features of satisfaction with breast appearance, outcome satisfaction and 
quality of life. Moreover, psychosocial wellbeing was a key predictor of both satisfaction 
with breast appearance and outcome satisfaction. Previous literature also indicates aesthetic 
satisfaction promotes greater psychological wellbeing [12]. This study demonstrated women 
with greater psychological wellbeing are more likely to report greater satisfaction with breast 
appearance and outcome satisfaction. In line with previous research, we suggest the 
possibility of a relationship, whereby satisfaction with breast appearance promotes greater 
psychosocial wellbeing and greater psychosocial wellbeing promotes breast and outcome 
satisfaction. This finding has important clinical implications and demonstrates a need to 
consider the pre-existing psychosocial wellbeing of patients prior to breast reconstruction, in 
order to enhance optimal post-mastectomy outcomes. Moderator analysis demonstrated the 
date of reconstruction significantly predicted satisfaction of breast appearance. As the date of 
reconstruction increased satisfaction with breast appearance increased, this finding could be 
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attributed to the continuously advancing reconstructive techniques offered. However, we 
must also consider if women are less satisfied with earlier reconstructive procedures due to 
the time lag between use of services and evaluation of satisfaction, this may indicate 
satisfaction with reconstruction decreases overtime.   
Unexpectedly as breast sensitivity increased, outcome satisfaction decreased. Breast 
sensitivity as a predictor of satisfaction has not been explored fully within current literature 
and warrants further consideration in future studies. Expectedly, as scarring pain increased 
outcome satisfaction decreased. Moreover, as scar thickness increased, satisfaction with the 
overall outcome increased. We speculate that some participants may have struggled to 
provide a precise scar thickness score. Although, these findings are inconsistent with previous 
qualitative scarring literature [32] they are undoubtedly of interest and warrant further 
consideration. Moreover, reconstruction type was associated with outcome satisfaction. DIEP 
patients reported greater satisfaction with the overall outcome compared to other types of 
reconstruction. Previous literature has reported higher satisfaction rates with autologous 
tissue based procedures than implant based reconstructions [26]. However, although greater 
patient satisfaction and cosmetic outcome is observed with the DIEP flap technique compared 
to other surgical procedures, there is no difference in reported quality of life [40]. This is 
consistent with the finding of the present study and suggests that procedure type effects both 
breast and outcome satisfaction but not overall quality of life. It may be that DIEP 
reconstruction enables women to perceive their reconstructed breasts, as a natural part of their 
own body which is not the case in implant reconstruction [7].  
Study Limitations 
The present study sought to control for many of the shortcomings identified in previous 
literature [34]. Consequently, all outcomes were clearly defined and distinguished, 
standardised measures were validated within the same clinical population, the effect of 
scarring was considered and a multiple surgeon design was applied. Nevertheless, selection 
bias is possible as participants were identified by two Plastic Surgeons from one NHS site 
and the majority of participants elected for a DIEP reconstruction. Other limitations include 
the omission of pre-surgical data and the cross-sectional study design which does not 
distinguish the direction of the relationships or account for the changing nature of the 
outcomes over time, and as satisfaction is thought to fluctuate during long-term survivorship 
this limitation may be of particular importance. Additionally, some clinical characteristics 
could not be ascertained including other treatment types, the number of reconstructive 
surgeries and any reconstructive complications. Moreover, only a small sample of women 
elected for delayed reconstruction, therefore we were unable to examine if the timing of 
reconstruction moderated the dependent outcomes. Future studies should be prospective, 
longitudinal and possibly of a qualitative design to provide a comprehensive understanding of 
the trajectory of satisfaction and quality of life following breast reconstruction.  
Clinical Implications  
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This study breaks down the concept of satisfaction and distinguishes between satisfaction 
with breast appearance and outcome satisfaction in order to provide evidence for key 
predictors of individual components of satisfaction. The findings of this study could be used 
to inform women of the predictors of satisfaction and quality of life following post-
mastectomy breast reconstruction. This would allow women to identify specific areas of 
focus which may require further surgical or psychological intervention to enhance both 
satisfaction and quality of life. Additionally, the findings demonstrate the need for healthcare 
providers to consider the psychosocial wellbeing of patients both pre and post operatively. 
The findings also provide preliminary evidence for the use of the extensive and complex 
DIEP procedure over other types of reconstructive techniques, although further longitudinal 
comparison studies are required.  
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